Search Results - "NAVETTA, F. I"

Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina : A randomized multicenter trial by SCHULMAN, S. P, GOLDSCHMIDT-CLERMONT, P. J, LINCOFF, A. M, YAKUBOV, S. J, BRAY, P. F, BAHR, R. D, WOLFE, C. L, YOCK, P. G, VERNON ANDERSON, H, NYGAARD, T. W, MASON, S. J, EFFRON, M. B, TOPOL, E. J, FATTERPACKER, A, RASKIN, S, SMITH, J, BRASHEARS, L, GOTTDIENER, P, DU MEE, C, KITT, M. M, GERSTENBLITH, G, CALIFF, R. M, NAVETTA, F. I, WILLERSON, J. T, CHANDRA, N. C, GUERCI, A. D, FERGUSON, J. J, HARRINGTON, R. A

“…Although aspirin is beneficial in patients with unstable angina, it is a relatively weak inhibitor of platelet aggregation. The effect of Integrelin, which…”
Get full text

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study by STEINHUBL, Steven R, TALLEY, J. David, GALLO, Richard, SANE, David C, SAUCEDO, Jorge F, JIA, Gang, LINCOFF, A. Michael, THEROUX, Pierre, HOLMES, David R, TEIRSTEIN, Paul S, KEREIAKES, Dean J, BRADEN, Gregory A, TCHENG, James E, CASTERELLA, Peter J, MOLITERNO, David J, NAVETTA, Frank I, BERGER, Peter B, POPMA, Jeffrey J, DANGAS, George

“…The optimal level of platelet inhibition with a glycoprotein (GP) IIb/IIIa antagonist necessary to minimize thrombotic complications in patients undergoing a…”
Get full text

Single-channel studies on linear gramicidins with altered amino acid side chains. Effects of altering the polarity of the side chain at position 1 in gramicidin A by Russell, E.W., Weiss, L.B., Navetta, F.I., Koeppe, R.E., Andersen, O.S.

“…The modulation of gramicidin A single-channel characteristics by the amino acid side chains was investigated using gramicidin A analogues in which the NH2…”
Get full text

Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty by Ellis, S G, Tcheng, J E, Navetta, F I, Muller, D W, Weisman, H F, Smith, C, Anderson, K M, Califf, R M, Topol, E J

“…Excessive platelet deposition at the site of arterial damage due to coronary angioplasty plays an important role in the pathophysiology of both abrupt closure…”
Get more information

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention by TCHENG, J. E, HARRINGTON, R. A, MILLER, J. A, JOSEPHD. M, SIGMON, K. N, KITT, M. M, DU MEE, C. P, CALIFF, R. M, TOPOL, E. J, KOTTKE-MARCHANT, K, KLEIMAN, N. S, ELLIS, S. G, KEREIAKES, D. J, MICK, M. J, NAVETTA, F. I, SMITH, J. E, WORLEY, S. J

“…Background Platelet aggregation and thrombosis have been implicated in the pathogenesis of coronary angioplasty complications. Integrelin, a synthetic cyclic…”
Get full text

Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris by Jackman, John D., Navetta, Frank I., Smith, Jack E., Tcheng, James E., Davidson, Charles J., Phillips, Harry R., Califf, Robert M., Nelson, Charlotte L., Gardner, Laura H., Stack, Richard S.

“…There are limited data regarding percutaneous transluminal coronary angioplasty (PTCA) in patients aged >80 years, a rapidly expanding population that has a…”
Get full text

Predicting the risk of abrupt vessel closure after angioplasty in an individual patient by Tenaglia, Alan N., Fortin, Donald F., Califf, Robert M., Frid, David J., Nelson, Charlotte L., Gardner, Laura, Miller, Michael, Navetta, Frank I., Smith, Jack E., Tcheng, James E., Stack, Richard S.

“…Objectives. We proposed to examine the relation between angiographic morphologic characteristics and abrupt closure after coronary angioplasty and to develop…”
Get full text

Combined accelerated tissue-plasminogen activator and Platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute Myocardial Infarction : Results of a randomized, placebo-controlled, dose-ranging trial by OHMAN, E. M, KLEIMAN, N. S, MILLER, M, KEREIAKES, D, YAKUBOV, S, KITT, M. M, SIGMON, K. N, CALIFF, R. M, KRUCOFF, M. W, TOPOL, E. J, GACIOCH, G, WORLEY, S. J, NAVETTA, F. I, TALLEY, J. D, ANDERSON, H. V, ELLIS, S. G, COHEN, M. D, SPRIGGS, D

“…Background Platelet activation and aggregation may be key components of thrombolytic failure to restore and maintain perfusion in acute myocardial infarction…”
Get full text

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization by Topol, E J, Califf, R M, Lincoff, A M, Tcheng, J E

“…New strategies for preventing ischemic complications during percutaneous coronary revascularization have focused on the platelet surface-membrane glycoprotein…”
Get full text

Trial of abciximab with and without low-dose reteplase for acute myocardial infarction

“…Background —Low-dose alteplase with standard-dose abciximab enhances reperfusion 90 minutes after acute myocardial infarction (MI). We combined standard-dose…”
Get full text

Acute myocardial infarction associated with initial cocaine use by Wehbie, C S, Vidaillet, Jr, H J, Navetta, F I, Peter, R H

“…We have described a young man who had acute myocardial infarction after his first use of cocaine. This case demonstrates that potentially lethal myocardial…”
Get more information

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery by Boehrer, James D., Kereiakes, Dean J., Navetta, Frank I., Califf, Robert M., Topol, Eric J., The EPIC Investigators

“…In conclusion, this report of 58 patients undergoing emergency bypass surgery after coronary angioplasty demonstrates that surgery can be performed after…”
Get full text

Myocardial ischemia in constrictive pericarditis by Navetta, F I, Barber, M J, Gurbel, P A, Moreadith, R W, Bernstein, R, Hlatky, M A, Coleman, R E, Bashore, T M

Get more information

Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty by Gurbel, Paul A., Navetta, Frank I., Bates, Eric R., Muller, David W., Tenaglia, Alan N., Miller, Michael J., Muhlstein, Brent, Hermiller, James B., Davidson, Charles J., Aguirre, Frank V., Beauman, Glenn J., Berdan, Lisa G., Leimberger, Jeffrey D., Bovill, Edwin G., Christenson, Robert H., Ohman, E. Magnus

“…Percutaneous coronary revascularization in patients with unstable angina and coronary thrombus carries a high complication rate. A new strategy to reduce…”
Get full text

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications by Boehrer, J D, Kereiakes, D J, Navetta, F I, Califf, R M, Topol, E J

Get full text

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators by Ohman, E M, Kleiman, N S, Gacioch, G, Worley, S J, Navetta, F I, Talley, J D, Anderson, H V, Ellis, S G, Cohen, M D, Spriggs, D, Miller, M, Kereiakes, D, Yakubov, S, Kitt, M M, Sigmon, K N, Califf, R M, Krucoff, M W, Topol, E J

“…Platelet activation and aggregation may be key components of thrombolytic failure to restore and maintain perfusion in acute myocardial infarction. We…”
Get full text

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators by Tcheng, J E, Harrington, R A, Kottke-Marchant, K, Kleiman, N S, Ellis, S G, Kereiakes, D J, Mick, M J, Navetta, F I, Smith, J E, Worley, S J

“…Platelet aggregation and thrombosis have been implicated in the pathogenesis of coronary angioplasty complications. Integrelin, a synthetic cyclic heptapeptide…”
Get full text

Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus underoing angioplasty by GURBEL, P. A, NAVETTA, F. I, BEAUMAN, G. J, BERDAN, L. G, LEIMBERGER, J. D, BOVILL, E. G, CHRISTENSON, R. H, OHMAN, E. M, BATES, E. R, MULLER, D. W, TENAGLIA, A. N, MILLER, M. J, MUHLSTEIN, B, HERMILLER, J. B, DAVIDSON, C. J, AGUIRRE, F. V

Get full text